0001562180-24-004838.txt : 20240607
0001562180-24-004838.hdr.sgml : 20240607
20240607162126
ACCESSION NUMBER: 0001562180-24-004838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bilenker Joshua H.
CENTRAL INDEX KEY: 0001612312
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 241029772
MAIL ADDRESS:
STREET 1: C/O LOXO ONCOLOGY, INC.
STREET 2: ONE LANDMARK SQUARE, SUITE 1122
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-06-06
false
0001770121
Sana Biotechnology, Inc.
SANA
0001612312
Bilenker Joshua H.
C/O SANA BIOTECHNOLOGY, INC.
188 EAST BLAINE STREET, SUITE 400
SEATTLE
WA
98102
true
false
false
false
false
Stock Option (Right to Buy)
7.36
2024-06-06
4
A
false
54278.00
0.00
A
2034-06-05
Common Stock
54278.00
54278.00
D
The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.
/s/ Julie Shah, Attorney-in-Fact for Joshua H. Bilenker
2024-06-07